- Home
- About
A focused firm for one specific question
How do rare neurology therapies reach patients in Türkiye, and who should bring them? That is the only question we work on.
Why we exist
Good partners exist. Neutral information often does not.
Genetic disease is more common in Türkiye than in Western Europe and diagnosis is slow. Experienced local partners and a reimbursed named-patient route exist; what is often missing is reliable, neutral information to decide quickly.
We provide that information. We help biotech companies decide whether and how to bring an approved rare neurology therapy to Türkiye, and help Turkish pharmaceutical companies find the therapies their patients are waiting for.
We do not import, store, distribute or promote medicines. Licensed Turkish partners do that.
Nadide.
- Language
- Turkish
- Pronunciation
- /na-dee-deh/
- Meaning
- Rare and precious
Our role
What we are, and what we are not
We are
- Independent advisers on rare neurology in Türkiye
- A source of sourced, decision-ready analysis
- A structured route between licence holders and qualified Turkish partners
We are not
- An importer, distributor or seller of medicines
- A promoter of any medicine to physicians or the public
- A holder of identifiable patient data
Team
A focused core team
A focused core team, with independent specialists engaged per project.
Ata Yağız Özön
Founder
Scientific advisory board
To be announced shortly
Neurologists and clinical geneticists.
Independent specialists
Engaged per project
Medical experts work under written, fair-market-value agreements, with interests disclosed.
Bringing a rare neurology therapy to Türkiye, or looking for one?
Tell us what you are working on. We reply within two working days.